These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36169546)

  • 1. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
    Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
    AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
    Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T
    Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New MRI features improve subtype classification of hepatocellular adenoma.
    Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
    Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping.
    Reizine E; Ronot M; Pigneur F; Purcell Y; Mulé S; Dioguardi Burgio M; Calderaro J; Amaddeo G; Laurent A; Vilgrain V; Luciani A
    Eur Radiol; 2019 Jul; 29(7):3791-3801. PubMed ID: 30937584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
    Kim TH; Woo S; Ebrahimzadeh S; McInnes MDF; Gerst SR; Do RK
    AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular adenoma subtyping by qualitative MRI features and machine learning algorithm of integrated qualitative and quantitative features: a proof-of-concept study.
    Liu X; Espin-Garcia O; Khalvati F; Namdar K; Fischer S; Haider MA; Jhaveri KS
    Clin Radiol; 2023 Sep; 78(9):679-686. PubMed ID: 37365116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
    Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
    Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas.
    Tse JR; Naini BV; Lu DS; Raman SS
    Radiology; 2016 Apr; 279(1):118-27. PubMed ID: 26505921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
    Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
    Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic hedgehog hepatocellular adenoma: magnetic resonance imaging features and correlation with histology.
    Ducatel A; Trillaud H; Reizine E; Vilgrain V; Sempoux C; Schmidt-Kobbe S; Gouw ASH; de Haas RJ; Julien C; Paradis V; Blanc JF; Chiche L; Balabaud C; Bioulac-Sage P; Frulio N
    Eur Radiol; 2024 Jul; 34(7):4649-4662. PubMed ID: 38012454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-Catenin-Mutated Hepatocellular Adenomas at Hepatobiliary Phase MRI: A Systematic Review and Meta-Analysis.
    Shen L; Altmayer S; Tse JR
    J Magn Reson Imaging; 2024 Nov; 60(5):2104-2114. PubMed ID: 38465878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
    Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
    Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
    J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course.
    Poetter-Lang S; Ba-Ssalamah A; Bastati N; Ba-Ssalamah SA; Hodge JC; Brancatelli G; Paradis V; Vilgrain V
    Br J Radiol; 2024 Nov; 97(1163):1740-1754. PubMed ID: 39235933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
    Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A
    Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
    Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
    Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.
    Thomeer MG; E Bröker ME; de Lussanet Q; Biermann K; Dwarkasing RS; de Man R; Ijzermans JN; de Vries M
    Diagn Interv Radiol; 2014; 20(3):193-9. PubMed ID: 24509184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
    Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
    AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
    Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
    AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.